Skip to main content
Fig. 1 | BMC Medical Genomics

Fig. 1

From: Despite low viral titer in saliva samples, Sanger-based SARS-CoV-2 spike gene sequencing is highly applicable for the variant identification

Fig. 1

a Distribution of SARS-CoV-2 viral titer in 241 saliva samples stratified by SARS-CoV-2 variants. This figure shows that the SARS-CoV-2 viral titers differed by the variant types, where the black circle spots represent Illumina NextSeq2000 NGS ( +) and Sanger ( +), the white circle spots represent Illumina NextSeq2000 NGS (-) but Sanger ( +). b Distribution of SARS-CoV-2 viral titer in 241 saliva samples stratified by amplification status. This figure shows that SARS-CoV-2 viral titer differed by the amplification status of the Sanger platform and Illumina NextSeq2000 NGS platform. The black circle spots represent the samples amplified by both the Sanger and the Illumina NextSeq2000 NGS platforms, the white circle spots for the samples amplified only by the Sanger platform, and the white diamond spots represent the samples that were not amplified at all by both platforms

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us